Primary Site >> Colorectal Cancer
Gene >> TNFRSF4
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134). PMID: 12034383 Ref: OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases. PMID: 12377195 |
Ref: Assessment expression of the adhesion molecules, CD134 and CD137, in patients with colorectal cancer by flow cytometry. PMID: 15638367 |
Ref: Determination of the activity of CD134 (OX-40) and CD137 (4-1BB) adhesive molecules by means of flow cytometry in patients with colorectal cancer metastases to the liver. PMID: 22166715 Ref: Assessment of activity of an adhesion molecule CD134 and CD137 in colorectal cancer patients. PMID: 22343199 |
Ref: B cell regulation of anti-tumor immune response. PMID: 24293009 |
Ref: PD-L1 blockade for cancer treatment: MEDI4736. PMID: 25965366 Ref: OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer. PMID: 26439988 |
Ref: Soluble OX40L favors tumor rejection in CT26 colon carcinoma model. PMID: 27203665 Ref: Immunotherapy of Colorectal Cancer. PMID: 27259331 Ref: Gp96-Ig/Costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T-cell Priming and Enhances Immunity, Memory, and Tumor Elimination. PMID: 27364122 Ref: Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer. PMID: 27622025 |
Ref: Distinct Blood and Visceral Adipose Tissue Regulatory T Cell and Innate Lymphocyte Profiles Characterize Obesity and Colorectal Cancer. PMID: 28649243 Ref: Pseudoprogression in microsatellite instability-high colorectal cancer during treatment with combination T cell mediated immunotherapy: a case report and literature review. PMID: 28915720 |